3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
14
Lung Neoplasms
8
Prostatic Neoplasms
6
Colorectal Neoplasms
6
Neoplasms
5
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Smoking Cessation
2
Skin Carcinoma
2
Pain
2
Melanoma
2
Malignant Solid Neoplasm
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Smoking
1
Testicular Neoplasms
1
Spondylitis, Ankylosing
1
Smoking
1
Signs and Symptoms
1
Sepsis
1
Rectal Neoplasms
1
Psoriasis
1
Interventions
Cyclophosphamide
15
fludarabine
12
Mycophenolic Acid
10
Standard of Care
8
venetoclax
7
Whole-Body Irradiation
7
Tacrolimus
7
Specimen Handling
7
Sirolimus
6
trametinib
5
Practice Guidelines as Topic
5
Azacitidine
5
fludarabine phosphate
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
Rituximab
3
Radiosurgery
3
Peripheral Blood Stem Cell Transplantation
3
Mesna
3
Interviews as Topic
3
Granulocyte Colony-Stimulating Factor
3
GSK2636771
3
Filgrastim
3
Cytarabine
3
Crizotinib
3
Busulfan
3
Behavior Therapy
3
talquetamab
2
ruxolitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Methods
×
90 days
×
Clear all
NCT04960787
2026-05-14
CREDIT
SWOG Cancer Research Network
Phase NA
Active not recruiting
331 enrolled